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Introduction: Substantial weakness of the quadriceps muscles is typically observed in patients with arthritis. This is
partly due to ongoing neural inhibition that prevents the quadriceps from being fully activated. Evidence from animal
studies suggests enhanced flexion reflex excitability may contribute to this weakness. This prospective observational
study examined the effects of joint aspiration and intra-articular corticosteroid injection on flexion reflex excitability,
quadriceps muscle strength and knee pain in individuals with knee synovitis.
Methods: Sixteen patients with chronic arthritis and clinically active synovitis of the knee participated in this study.
Knee pain flexion reflex threshold, and quadriceps peak torque were measured at baseline, immediately after knee joint
aspiration alone and 5 ± 2 and 15 ± 2 days after knee joint aspiration and the injection of 40 mg of methylprednisolone
acetate.
Results: Compared to baseline, knee pain was significantly reduced 5 (p = 0.001) and 15 days (p = 0.009) post
intervention. Flexion reflex threshold increased immediately after joint aspiration (p = 0.009) and 5 (p = 0.01) and
15 days (p = 0.002) post intervention. Quadriceps peak torque increased immediately after joint aspiration (p = 0.004)
and 5 (p = 0.001) and 15 days (p <0.001) post intervention.
Conclusions: The findings from this study suggest that altered sensory output from an inflamed joint may increase
flexion reflex excitability in humans, as has previously been shown in animals. Joint aspiration and corticosteroid
injection may be a clinically useful intervention to reverse quadriceps muscle weakness in individuals with knee
synovitis.Introduction
Quadriceps strength deficits of 20–40 % are typically
observed in individuals with knee joint arthritis. This is
partly due to muscle atrophy and partly due to ongoing
neural inhibition that prevents the quadriceps from
being fully activated by the central nervous system (i.e. a* Correspondence: david.rice@aut.ac.nz
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known as arthrogenic muscle inhibition (AMI). Quadri-
ceps AMI has been linked to joint effusion, inflamma-
tion and pain, joint laxity and articular structural
damage [2]. The relative importance of these factors is
unclear but it is generally accepted that AMI is caused
by a change in the discharge of sensory receptors from
the damaged knee joint [2, 3]. Abnormal joint afferent
discharge may have powerful effects on the excitability
of several central nervous system pathways that combine
to prevent full activation of the quadriceps muscles
(for a review see [4]). As well as being a direct cause ofle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Participant characteristics
Age in years, mean (SD) 61.0 (13.7)
Height in metres, mean (SD) 1.65 (0.09)
Mass in kilograms, mean (SD) 81.9 (22.6)
Female, number (%) 11 (68.8)
Duration of pathology in months, mean (SD) 98.8 (78.3)
Type of pathology, number (%)
Rheumatoid arthritis 10 (62.50)
Osteoarthritis 5 (31.25)
Psoriatic arthritis 1 (6.25)
Number of painful joints, mean (SD) 3 (3.25)
SD standard deviation
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atrophy [2] and, in more severe cases, can prevent
effective quadriceps strengthening [5], leading to persist-
ent muscle weakness that is difficult to reverse. Ongoing
quadriceps weakness is clinically important as it may
impair dynamic knee joint stability [6], physical function
[7, 8] and quality of life [8] as well as increasing the risk
of further joint damage [9].
A number of experimental studies [10–12] have dem-
onstrated that joint effusion is an important cause of AMI,
with immediate reductions in quadriceps peak torque,
electromyography (EMG) amplitude and H-reflex ampli-
tude observed following the infusion of normal saline into
healthy, uninjured knee joints. Similar experiments in
animals [13, 14] have shown that joint infusion raises
intra-articular pressure, stimulating stretch and pressure-
sensitive articular mechanoreceptors and greatly enhan-
cing the discharge of group II joint afferents.
While the aspiration of fluid from arthritic knee joints
increases quadriceps peak torque, the subsequent infusion
of local anaesthetic [15] or corticosteroid [16] has been
shown to further enhance quadriceps muscle activation in
these individuals. Moreover, recent studies have demon-
strated that experimental knee pain leads to an immediate
reduction in quadriceps peak torque [17, 18], voluntary
muscle activation [17] and H-reflex amplitude [17], sug-
gesting that joint nociception also plays an important role
in quadriceps AMI. Both these mechanisms may be rele-
vant to arthritic joint disease, where joint effusion is often
perennial and the presence of inflammatory mediators
substantially increases nociceptive discharge by ongoing
peripheral sensitisation of group III and IV joint afferents
(for a review see [19]).
The specific central nervous system pathways (e.g. spinal
reflex and/or cortical pathways) by which abnormal joint
afferent output leads to AMI are only partially understood.
Several pathways may be affected by a change in joint affer-
ent discharge and may thus be involved in AMI [2, 4]. One
of the spinal reflex pathways thought to be involved is the
flexion reflex [2]. The flexion reflex is a polysynaptic path-
way that typically produces a pattern of flexor muscle fa-
cilitation and inhibition of extensor muscles such as the
quadriceps [20]. Studies in animals have shown that flexion
reflex is mediated, at least in part, by wide dynamic range
neurons in the spinal cord [21], and that these interneu-
rons receive excitatory sensory input from both mechano-
sensitive (group II) and nociceptive (group III and IV) knee
joint afferents [22]. Furthermore, animal studies have dem-
onstrated that experimentally induced knee joint arthritis
greatly increases the excitability of the flexion reflex
pathway [23, 24] and that this can be reversed by the
subsequent injection of local anaesthetic into the joint
[24]. Similarly, some cross-sectional studies in humans
have shown that flexion reflex excitability is enhancedin patients with knee joint injury or pathology compared
to healthy controls [25–27]. However, it has yet to be
demonstrated that modifying joint afferent discharge al-
ters flexion reflex excitability in humans and it is unknown
whether this is accompanied by an improvement in quad-
riceps muscle strength.
Thus, the purpose of this prospective observational
study was to explore the effects of knee joint aspiration
and corticosteroid injection on flexion reflex threshold,
quadriceps muscle strength and knee pain in individuals
with arthritis and clinically active knee joint synovitis.Methods
Participants
Sixteen participants with chronic knee joint arthritis (ten
rheumatoid arthritis (RA), five osteoarthritis (OA), one
psoriatic arthritis) who were attending outpatient rheuma-
tology or physiotherapy clinics volunteered to take part in
this study (Table 1). Participants were included if they had
a clinically detectable knee joint effusion (brush/stroke
test [28]) as well as other signs and symptoms of knee
joint synovitis (pain on motion, heat and tenderness on
palpation). They were excluded if they had received an
intra-articular injection in the preceding 4 months, a
cardiovascular condition precluding the performance of
maximum effort strength tests, a documented loss of
normal sensory function or a history of low back pain
with associated neurological symptoms and signs. Par-
ticipants were asked to refrain from caffeine, alcohol,
nicotine, and strenuous exercise for 4 hours prior to each
testing session [29]. In addition, they were asked not to
take any analgesic medication in the 12 hours prior to
each testing session but were otherwise told to continue
taking their usual medication. Finally, participants were
asked not to start any new medication or undertake any
unaccustomed exercise during the testing period. Ethical
approval for this study was given by the Northern Re-
gional X Ethics Committee of New Zealand in accordance
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Experimental protocol
Participants attended three testing sessions: baseline, 5 ±
2 days post intervention and 15 ± 2 days post interven-
tion. For each participant, testing was conducted at the
same time of day in each session to minimise circadian
variations in flexion reflex threshold [30] and muscle
strength [31]. At the baseline session, measures of knee
pain, flexion reflex threshold and quadriceps peak torque
were performed. A second baseline measure of flexion
reflex threshold was undertaken 15 minutes later to en-
sure the stability of this measure. Thereafter, participants
had their knee joint aspirated. Immediately following joint
aspiration, flexion reflex threshold and then quadriceps peak
torque were measured again. At the end of the baseline ses-
sion, participants received an intra-articular injection of 40
mg methylprednisolone acetate. Participants were advised to
rest the injected knee as much as possible in the first 72
hours after corticosteroid injection [32]. At 5 ± 2 days and
15 ± 2 days post intervention, knee pain, flexion reflex
threshold and quadriceps peak torque were retested.
Joint aspiration and corticosteroid injection
All participants had their knee joint aspirated while lying
in a supine position with the knee resting in or near full
extension. A 21-gauge needle was inserted into the super-
olateral aspect of the joint and as much synovial fluid as
possible withdrawn from the knee. Where aspiration
obtained notably less synovial fluid than expected from
clinical examination (n = 5), a second aspiration was
attempted using a medial approach. Following the post-
aspiration measures of the dependent variables, 40 mg
of methylprednisolone acetate (Depomedrol®) was injected
into the knee joint. All joint injections were performed
without local anaesthesia, under sterile conditions.
Knee pain
Knee pain ratings were obtained using the P4. The P4 is
a four-item instrument that gathers numerical pain ratings
of pain in the morning, pain in the afternoon, pain in the
evening and pain during activity [33] over the last 2 days.
The P4 has been validated in individuals with arthritis [34]
and has superior reliability and responsiveness compared
to single-item numerical pain rating scales [33].
Flexion reflex threshold
A Nicolet bar electrode (stimulating electrode) with 9 mm
gold cups and 30 mm interelectrode distance (Weaver
and Company, Aurora, CO, USA) was secured under
the medial arch of the foot and covered with an elastic
bandage. The stimulating electrode was placed in a
standardised position 2 cm proximal to the firstmetatarsophalangeal joint and directly underneath the
first metatarsal on the plantar aspect of the foot, with
the anode positioned distally. For recording purposes, bi-
polar Ag-AgCl disc electrodes with an interelectrode dis-
tance of 2.2 cm were placed over the biceps femoris
muscle of the ipsilateral leg, with the inferior edge posi-
tioned 10 cm above the popliteal crease [29]. A ground
electrode was placed on the anterior surface of the ipsilat-
eral tibia. Prior to placement of both the stimulating
and recording electrodes, the electrode sites were
shaved, abraded and cleansed with an alcohol wipe to re-
duce skin impedance. EMG signals were amplified (1000×),
filtered (10–1000 Hz; AMT-8 amplifier, Bortec Biomedical,
Calgary, AL, Canada), and sampled at 2000 Hz (Micro 1401,
Cambridge Electronic Design, Cambridge, UK).
Once the stimulating and recording electrodes were in
place, participants stood on a raised, carpeted wooden
block (150 × 40 × 26 cm) and were asked to support
their weight through their contralateral leg and arms
while holding onto the back of a chair for balance. The
stimulated leg hung in a relaxed position without touch-
ing the ground. Participants were asked to look straight
ahead during testing and to keep the muscles in their
stimulated leg completely relaxed. Muscle relaxation was
ensured by continuous monitoring of biceps femoris sur-
face EMG in real time on an oscilloscope (Textronix
TDS2014B, Beaverton, OR, USA). The reliability of test-
ing the flexion reflex threshold in this manner has been
established in our laboratory [35]. Electrocutaneous stim-
uli were then delivered to the medial arch of the foot using
a DS7A constant current stimulator (Digitimer Ltd,
Welwyn Garden City, UK) controlled by a specialised
software programme (Signal 3, Cambridge Electronic
Design, Cambridge, UK). Each stimulus train consisted
of five rectangular pulses of 1 ms pulse width with a 3 ms
interpulse interval (17 ms total duration) [36]. Stimuli
were separated by a random interstimulus interval of
8–12 seconds [29]. Prior to threshold testing partici-
pants were familiarised with the stimulation procedures
by receiving a series of 15 stimuli of varying intensity.
The flexion reflex threshold was then determined using
an up-down staircase method [29]. Specifically, the stimu-
lation intensity was increased from 0 mA in 4 mA incre-
ments until a flexion reflex was observed. Once a flexion
reflex response was observed, the intensity was decreased
in 2 mA steps until a flexion reflex was no longer evi-
dent. The stimulation intensity was then increased and
decreased four more times in 1 mA increments until a
flexion reflex appeared twice and disappeared twice.
These final four stimulation intensities were recorded
and averaged to calculate flexion reflex threshold. The
presence of a flexion reflex response was defined using
a flexion reflex interval peak z-score of biceps femoris
EMG activity, derived using the formula [29]:
Z−score ¼ flexion reflex interval peak – baseline meanð Þ = baseline standard deviation
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femoris EMG activity were recorded from a 65 ms
period (−70 to −5 ms) prior to stimulation. The flexion
reflex interval peak refers to the peak EMG activity of
the biceps femoris muscle during the post stimulation
window of 85–150 ms. This window was chosen to avoid
signal contamination via non-nociceptive reflexes and
startle responses [37]. A z-score of 10.32 or greater was
considered a true flexion reflex response [29].Quadriceps peak torque
Participants were seated in a custom-designed chair with
the hips and knees flexed to 90°. Straps were firmly se-
cured over the distal third of the thigh and across the
chest to limit extraneous movement. A rigid strap was
secured around the ankle, slightly superior to the malle-
oli. This was coupled in series to a uniaxial load cell
(Precision Transducers, Auckland, New Zealand), aligned
horizontally with the ankle joint. All participants were
asked to perform isometric maximum voluntary contrac-
tions (MVCs) of their quadriceps by pushing as hard as
possible against the ankle strap. Prior to maximum effort
contractions, a series of four submaximal quadriceps
contractions (25 %, 50 %, 50 % and 75 % of perceived
maximum effort) were performed, with a 1-minute rest
given between each contraction. These were performed
as “warm-up” contractions in an attempt to minimise
the risk of participant injury and facilitate muscle force
production during subsequent maximum effort con-
traction [38, 39]. Thereafter, a 2-minute rest was given
before a set of three (6-second) MVCs were performed.
Participants received visual feedback of their force trace
and a consistent level of strong verbal encouragement
during each contraction. A 2-minute rest period was
given between each maximum effort contraction. In the
event that the peak force (N) produced during the
MVCs continued to increase with each subsequent trial
(six participants), a fourth, and in some cases a fifth,
contraction was performed until force plateaued or de-
creased. This was done in an effort to elicit a true max-
imum effort from each individual. Force signals were
recorded from the load cell during each contraction,
where they were amplified (×100), sampled (1000 Hz)
and stored on a computer for later analysis. At each
measurement interval, peak isometric quadriceps strength
was calculated as the highest force (N) produced during
any of the three to five MVCs. The length of the lever arm
was measured from the lateral epicondyle of the femur to
the centre of the ankle strap, which was parallel to theload cell. Lever arm length (m) was then multiplied by
peak isometric force (N) to calculate peak torque (Nm).
Statistical analysis
To assess whether the dependent variables conformed to
a normal distribution Shapiro-Wilk tests were completed.
One-way repeated measures ANOVAs were undertaken
to analyse differences in flexion reflex threshold and
quadriceps peak torque over time (baseline, day 5, and
day 15). Where the assumption of sphericity was violated,
Greenhouse-Geisser corrections were utilised. As our a
priori hypotheses were that flexion reflex threshold and
quadriceps peak torque would increase following aspiration
and corticosteroid injection, planned contrasts were used
to assess the differences between the first (baseline 1) and
each subsequent measure. As the P4 pain scores were not
normally distributed, a Friedman’s test was used to exam-
ine changes in knee pain over time. Thereafter, Wilcoxon
signed-rank tests were utilised to compare baseline knee
pain to knee pain on day 5 and day 15. The alpha level for
all statistical procedures was set to 0.05.
Results
Baseline characteristics of the participants are provided
in Table 1. The mean volume of fluid aspirated from the
knee joint was 24 ± 27 ml. Quadriceps peak torque was
collected from all 16 participants. Complete data sets for
measures of flexion reflex threshold could only be obtained
from 11 of the 16 participants. One participant with RA
was unable to support their body weight on the contralat-
eral leg due to painful synovitis in the first metatarsopha-
langeal joint. Equipment failure prevented flexion reflex
threshold being collected at day 5 for two participants and
day 15 for two participants. All participants acted appropri-
ately in respect to the instructions regarding exercise
changes and medication use during the testing period.
Knee pain
There was a significant change in knee pain over time
(p <0.001) (Fig. 1). Compared to baseline, there was a sig-
nificant reduction in knee pain at 5 ± 2 days (p = 0.001)
and 15 ± 2 days (p = 0.009) after aspiration and cortico-
steroid injection.
Flexion reflex threshold
A significant change in flexion reflex threshold was ob-
served over time (p = 0.002) (Fig. 2). Flexion reflex thresh-
old was significantly higher than baseline after aspiration
alone (p = 0.009) and at 5 ± 2 days (p = 0.01) and 15 ± 2
Fig. 1 Knee pain as measured on the P4 instrument before and
after knee joint aspiration and corticosteroid injection. Baseline =
before intervention. Day 5 = 5 ± 2 days after knee joint aspiration
and corticosteroid injection. Day 15 = 15 ± 2 days after knee joint
aspiration and corticosteroid injection. **= significant change from
baseline (p <0.01). ***= significant change from baseline (p = 0.001).
Data are means and one standard error of the mean
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jection. No significant difference was found between
the baseline 1 and baseline 2 measures of flexion reflex
threshold (p = 0.479).
Quadriceps peak torque
There was a significant change in quadriceps peak torque
over time (p <0.001) (Fig. 3). Quadriceps peak torque wasFig. 2 Flexion reflex (FR) threshold before (baseline 1 and baseline 2) and
after knee joint aspiration and corticosteroid injection. mA = milliamps.
Aspiration = following joint aspiration only. Day 5 = 5 ± 2 days after knee
joint aspiration and corticosteroid injection. Day 15 = 15 ± 2 days after
knee joint aspiration and corticosteroid injection. *= significant change
from baseline 1 (p <0.05). **= significant change from baseline 1
(p <0.01). Data are means and one standard error of the meansignificantly higher than baseline after aspiration alone
(p = 0.004) and at 5 ± 2 days (p = 0.001) and 15 ± 2 days
(p <0.001) after aspiration and corticosteroid injection.
Discussion
The findings of this study provide evidence that altered
knee joint afferent discharge modifies flexion reflex excit-
ability in humans, as has previously been demonstrated in
animals [24]. We observed an increase in flexion reflex
threshold immediately after the aspiration of fluid from
the joint and a larger increase 5 and 15 days after subse-
quent corticosteroid injection. Knee joint effusion is an
established cause of AMI, with experimental joint infusion
leading to immediate decreases in quadriceps strength
and muscle activation that can be reversed or prevented
by the intra-articular injection of local anaesthethic.
Recent findings [40] have failed to demonstrate a role
of cortical pathways in this inhibition. However, experi-
mental joint infusion markedly suppresses the quadriceps
H-reflex amplitude [11, 41] (a measure of spinal reflex
excitability) and has been shown to enhance group I
non-reciprocal (Ib) inhibition of the quadriceps moto-
neuron pool, both at rest and during voluntary muscle
contraction [42]. In the current study, the reduction in
flexion reflex excitability following aspiration alone is a
novel finding, suggesting that joint effusion may enhance
flexion reflex excitability as well as increasing the excit-
ability of other spinal reflex inhibitory pathways such as
group I non-reciprocal (Ib) inhibition [4].
In humans, experimental joint effusion rarely evokes
sensations of pain [12], suggesting that that effusion alone
is unlikely to stimulate a significant number of nociceptive
(group III and IV) afferents. Furthermore, in animal stud-
ies, the infusion of saline into undamaged knee joints
failed to increase flexion reflex excitability [23]. However,
the afferent response to effusion may differ markedly in
arthritic joints, where the presence of inflammatory medi-
ators directly activates a portion of group III and IV joint
afferents while at the same time sensitising these afferents
to previously innocuous mechanical stimuli such as an in-
crease in intra-articular pressure [43]. Furthermore, cen-
tral sensitisation of wide dynamic range interneurons may
increase the synaptic efficacy of group II joint afferents
acting on the flexion reflex pathway, as these interneurons
are thought to be involved in mediating the flexion reflex
response [21, 44]. Thus, in the presence of synovitis, it is
likely that aspiration reduces the discharge of group II, III
and IV knee joint afferents, all of which have the potential
to influence flexion reflex excitability.
The increase in flexion reflex threshold 5 and 15 days
after aspiration and corticosteroid injection may be ex-
plained by the anti-inflammatory effects of corticoster-
oid injection and subsequent reduction in the discharge
of group III and IV afferents. Locally administered
Fig. 3 Quadriceps peak torque at baseline and following knee joint aspiration and corticosteroid injection. Nm = Newton metres. Aspiration = following
joint aspiration only. Day 5 = 5 ± 2 days after knee joint aspiration and corticosteroid injection. Day 15 = 15 ± 2 days after knee joint aspiration and
corticosteroid injection. **= significant change from baseline (p <0.01). ***= significant change from baseline (p ≤0.001). Data are means and one
standard error of the mean
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tory effect on the ability of group IV afferents to gener-
ate action potentials [45]. Furthermore, corticosteroid
injections are known to strongly suppress local joint
inflammation [46] and thus can be expected to both
reduce the activation of chemosensitive free nerve end-
ings and raise the activation threshold of group III and
IV joint afferents affected by peripheral sensitisation.
The subsequent reduction in articular sensory output
may reduce spatial facilitation between nociceptive cu-
taneous afferents in the foot and joint afferents [20],
increasing the flexion reflex threshold. Alternatively, it
is possible a reduction in nociceptive input from the
arthritic joint partially reverses neuroplastic changes in
the spinal cord interneurons, mediating the flexion re-
flex response. Such a reduction in central nervous sys-
tem excitability following the removal or blockade of
peripheral afferent input has been observed previously
[47–49]. Finally, it is possible that aspiration and cor-
ticosteroid injection led to a change in descending in-
hibition and/or facilitation of the flexion reflex from
supraspinal structures. In this regard, Herrero et al. [50]
have shown that supraspinal pathways are at least partly
responsible for the increase in flexion reflex excitability
observed in cats during experimental knee arthritis. Fur-
thermore, in humans, a reversal in the dysfunction of con-
ditioned pain modulation pathways has been shown after
both knee [48] and hip [51] arthroplasty. As conditioned
pain modulation is at least partly determined by
supraspinal inhibition of wide dynamic range neurons
[52], it is possible that reducing the nociceptive barrage
from the damaged joint may enhance descending inhib-
ition and/or reduce descending facilitation of the flexion
reflex pathway [48, 51].An important finding from the current study is that
aspiration and corticosteroid injection led to a notable
increase in quadriceps peak torque in individuals with
chronic knee joint arthritis. These findings support the
earlier work of Geborek et al. [16], who reported a 9 Nm
increase in quadriceps peak torque immediately after
knee joint aspiration and a larger 26 Nm increase 14
days after subsequent corticosteroid injection in RA pa-
tients. Similarly, we observed a 9 ± 10 Nm increase in
torque immediately following aspiration and a 31 ± 19 Nm
increase by day 15, an average 25 % increase in quadriceps
peak torque from baseline levels. Such a rapid change in
muscle strength is likely to reflect enhanced neural activa-
tion of the muscle as changes in muscle structure such as
fibre hypertrophy take longer than 15 days to occur, even
with heavy resistance training [53]. This is supported by
our finding of an immediate increase in quadriceps peak
torque following knee joint aspiration, which indicates the
presence of quadriceps AMI in our participants.
Quadriceps AMI is common in patients with RA [54]
and OA [55]. Interestingly, the mean 25 % increase in
quadriceps peak torque we observed 15 days after as-
piration and corticosteroid injection is of a similar mag-
nitude to the reported change in quadriceps strength
produced by 5–6 months of high-intensity resistance
training in some studies [56, 57]. While AMI does not
always preclude quadriceps strength gains [54], even
mild AMI can restrict their magnitude as a portion of
the muscle cannot be activated [58, 59]. Recent work in
patients with OA suggests that combining transcutaneous
electrical nerve stimulation (an intervention known to re-
duce AMI [60]) with resistance training produces greater
improvements in quadriceps activation and strength than
resistance training alone [59]. Furthermore, in patients
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inflammatory drugs (NSAIDs) and resistance training
has been shown to lead to greater increases in quadriceps
strength compared to resistance training and placebo tab-
lets [58]. Given the approximately 25 % increase in quadri-
ceps strength we observed in the current study, it may be
that aspiration and corticosteroid injection followed by a
period of resistance training will lead to greater long-term
quadriceps strength gains than resistance training alone in
patients with knee joint synovitis. This should be investi-
gated in future studies.
Limitations of this study include the relatively small
sample size and diversity in the underlying joint pathology.
However, all participants were included due to clinically
detectable synovitis and, despite the sample size, significant
changes were observed in all the dependent variables.
While we consider it more likely that our findings are
explained by a reduction in abnormal joint afferent out-
put, the pre-post design of our study and lack of a control
group means we cannot rule out non-specific treatment
effects such as placebo contributing to the observed ef-
fects. However, corticosteroid injection is known to have
potent anti-inflammatory effects at the injected joint; re-
ducing joint effusion [46], mast cell [61] and macrophage
[61] numbers; suppressing T cell production [62] and
reducing both pro-inflammatory cytokine [62] and leu-
kotriene [63] expression in the synovium. Furthermore,
the between-session reliability of the quadriceps peak
torque [64] and flexion reflex threshold [35] has been
established, placebo injection has previously been shown
to have no effect on quadriceps strength [65] and there is
level Ia evidence that corticosteroid injection has a
significant therapeutic effect over and above placebo
injection [66].
Conclusions
In this study, aspiration and corticosteroid injection of
chronic arthritic knee joints led to a significant increase
in flexion reflex threshold, suggesting that aberrant joint
afferent output due to effusion and inflammation enhances
flexion reflex excitability in humans as has previously been
observed in animals. Furthermore, aspiration and cortico-
steroid injection led to a mean 25 % increase in quadriceps
peak torque after 15 days, suggesting a clinically important
reduction in quadriceps AMI. Future research in patients
with knee synovitis should explore whether quadriceps re-
sistance training can be enhanced by the prior aspiration
and injection of corticosteroid into the joint.
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